Autres langues BioMarin Pharmaceutical Inc.

Actions

BMRN

US09061G1013

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
80,69 ^USD	-0,20 %		+7,49 %	-16,31 %

07/06	BioMarin Pharmaceutical annonce de nouvelles données confirmant l'innocuité et l'efficacité à long terme de Roctavian	MT
31/05	Un initié de BioMarin Pharmaceutical a vendu des actions pour une valeur de 3 043 802 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioMarin Pharmaceutical Reports New Data Affirming Long-Term Safety, Efficacy of Roctavian	07/06
BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress	07/06
BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing	31/05
Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing	13/05
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT 1:00pm ET, in Las Vegas, NV	09/05
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV	08/05
Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing	06/05
New Data for BioMarin's VOXZOGO for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society Annual Meeting	06/05
Biomarin Pharmaceutical Inc. Announces Positive New Data Supporting the Safety and Efficacy of VOXZOGO® in Children	04/05
BioMarin Pharmaceutical Inc. Announces That Positive New Data Supporting the Safety and Efficacy of VOXZOGO® in Children	04/05
RACCOMANDAZIONI DEGLI ANALISTI USA/UK : Alphabet, Amgen, Starbucks, PayPal, Moderna...	03/05
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Alphabet, Amgen, Starbucks, PayPal, Moderna...	03/05
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	03/05
BioMarin Pharmaceutical Investors Overfocused on Roctavian, Distracted From Enzyme Replacement Therapies, UBS Says	29/04
BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours	24/04
BioMarin: Q1 Earnings Snapshot	24/04
(BMRN) BIOMARIN PHARMACEUTICAL Forecasts Fiscal Year 2024 EPS Range $2.75 - $2.95	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 Revenue $648.8M	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 EPS $0.71	24/04
BioMarin Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioMarin Pharmaceutical Inc.

Actions

BMRN

US09061G1013

Autres langues

Filtres